Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google ...

Demis Hassabis is the CEO of Google DeepMind. Demis thinks new agent type systems will be able to perform additional tree of ...

Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this ...

Google DeepMind co-founder & CEO Demis Hassabis speaks with columnist Bina Venkataraman about AI’s role in enabling scientific breakthroughs, why human-level intelligence is an “important ...

but Demis Hassabis did. And win it, he did. In October 2024, the British co-founder and chief executive officer of Google DeepMind received the Nobel Prize for Chemistry, sharing it with his ...

Researchers are identifying current and future dangers within AI models away from the conflicts of interest they’d face in ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

$540 $319 for your first year Make up your own mind. Build robust opinions on the FT's trusted journalism. Offer available ...

AI has already disrupted fields like coding, investment banking and law, but it looks to be poised to change yet another ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trials of drugs designed using AI to start late this year.

"Given that the companies behind the large language models have released them without sort of putting guardrails around their ...